To investigate the effects of Nogo/NgR pathway on pathological features of AD, NEP1-40 was intracerebroventricularly administered by continuous infusion into APP/PS1 mice aged from 6 to 8 months old with an Alzet mini-pump. The gene discussed is EMG1; the disease is Alzheimer disease.